Cas no 20261-38-5 (Ginkgolic Acid (C13:0))
Ginkgolic Acid (C13:0) Chemical and Physical Properties
Names and Identifiers
-
- Ginkgoneolic acid
- 6-Tridecylsalicylic acid
- Ginkgolic Acid (C13:0)
- 2-hydroxy-6-tridecylbenzoic acid
- 6-n-Tridecylsalicylic acid
- Ginkgolic Acid
- Ginkgolic acid C13:0
- Ginkgolic Acid C13-0
- Ginkgolic Acid C13:0
- 2-Hydroxy-6-tridecylbenzoic acid,6-Tridecylsalicylic acid,Ginkgoneolic acid
- 6-tridecyl anacardic acid
- 6-tridecyl phenol
- Benzoic acid,2-hydroxy-6-tridecyl
- Ginkgolic acid (13:0)
- Benzoic acid, 2-hydroxy-6-tridecyl-
- C20H32O3
- Salicylic acid, 6-tridecyl- (8CI)
- Salicylic acid, 6-tridecyl-
- 6-Tridecyl-Salicylic acid
- 2-Hydroxy-6-tridecyl-Benzoic acid
- Ginkgolic acid (13
- CS-3726
- AS-62129
- CHEBI:175101
- Ginkgolic acid C13:0, analytical standard
- BRN 2660108
- Ginkgolic acid (13:0);Ginkgoneolic Acid;6-Tridecylsalicylic acid
- Q63395389
- FT-0697966
- HY-N0078
- SCHEMBL20298323
- CHEMBL476921
- BDBM50259931
- Ginkgolic Acid (C130)
- NS00067884
- 2-TRIDECYL-6-HYDROXYBENZOIC ACID
- s9445
- DTXSID10174105
- MFCD01661602
- AKOS015888424
- CCG-267712
- 20261-38-5
- ConMedNP.3042
- DA-63758
- Benzoic acid, 2-hydroxy-6-tridecyl-; Salicylic acid, 6-tridecyl- (8CI); 2-Hydroxy-6-tridecylbenzoic acid; 6-Tridecylsalicylic acid; 6-n-Tridecylsalicylic acid; Ginkgoneolic acid
-
- MDL: MFCD01661602
- Inchi: 1S/C20H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-14-17-15-13-16-18(21)19(17)20(22)23/h13,15-16,21H,2-12,14H2,1H3,(H,22,23)
- InChI Key: VEPUCZUJLKAVNM-UHFFFAOYSA-N
- SMILES: OC1=CC=CC(=C1C(=O)O)CCCCCCCCCCCCC
- BRN: 2660108
Computed Properties
- Exact Mass: 320.23500
- Monoisotopic Mass: 320.23514488 g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 23
- Rotatable Bond Count: 13
- Complexity: 303
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 57.5
- Molecular Weight: 320.5
- XLogP3: 8.4
Experimental Properties
- Color/Form: Powder
- Density: 1.0180
- Melting Point: 85-86°C
- Boiling Point: 449.5℃/760mmHg
- Solubility: 0.006004 mg/L @ 25 °C (est)
- PSA: 57.53000
- LogP: 5.94390
Ginkgolic Acid (C13:0) Security Information
-
Symbol:
- Signal Word:Warning
- Hazard Statement: H315-H319-H335
- Warning Statement: P261-P305+P351+P338
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- Hazard Category Code: 36/37/38
- Safety Instruction: 26
-
Hazardous Material Identification:
- Storage Condition:Please store the product under the recommended conditions in the Certificate of Analysis.
Ginkgolic Acid (C13:0) Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | L-MY080-2mg |
Ginkgolic Acid (C13:0) |
20261-38-5 | ,≥98% | 2mg |
¥621.0 | 2022-02-28 | |
| MedChemExpress | HY-N0078-5mg |
Ginkgolic Acid (C13:0) |
20261-38-5 | 99.73% | 5mg |
¥600 | 2024-04-19 | |
| MedChemExpress | HY-N0078-10mg |
Ginkgolic Acid (C13:0) |
20261-38-5 | 99.73% | 10mg |
¥1050 | 2024-04-19 | |
| MedChemExpress | HY-N0078-50mg |
Ginkgolic Acid (C13:0) |
20261-38-5 | 99.73% | 50mg |
¥3150 | 2023-08-31 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | G115862-10mg |
Ginkgolic Acid (C13:0) |
20261-38-5 | ,≥98% | 10mg |
¥926.90 | 2023-09-02 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | G115862-50mg |
Ginkgolic Acid (C13:0) |
20261-38-5 | ,≥98% | 50mg |
¥3704.90 | 2023-09-02 | |
| ChemFaces | CFN98507-20mg |
Ginkgolic acid C13:0 |
20261-38-5 | >=98% | 20mg |
$218 | 2021-07-22 | |
| S e l l e c k ZHONG GUO | S9445-1mg |
Ginkgolic Acid (C13:0) |
20261-38-5 | 99.93% | 1mg |
¥1204.58 | 2023-09-15 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R021320-10mg |
Ginkgolic Acid (C13:0) |
20261-38-5 | 98%() | 10mg |
¥1112 | 2024-05-25 | |
| SHANG HAI YI EN HUA XUE JI SHU Co., Ltd. | R021320-50mg |
Ginkgolic Acid (C13:0) |
20261-38-5 | 98%() | 50mg |
¥8999 | 2022-09-30 |
Ginkgolic Acid (C13:0) Suppliers
Ginkgolic Acid (C13:0) Related Literature
-
Daijie Wang,Xiangyun Song,Huijiao Yan,Mengmeng Guo,Ruiming Fu,Hailong Jiang,Heng Zhu,Xiao Wang RSC Adv. 2018 8 34321
-
Na Cui,Liangliang Zhang,Meiping Quan,Jianguo Xu RSC Adv. 2020 10 45105
-
Xin-Guang Liu,Xu Lu,Wen Gao,Ping Li,Hua Yang Nat. Prod. Rep. 2022 39 474
-
Isaac Duah Boateng Food Funct. 2022 13 9226
-
Isaac Duah Boateng Food Funct. 2022 13 9226
Additional information on Ginkgolic Acid (C13:0)
Comprehensive Overview of Ginkgolic Acid (C13:0) (CAS No. 20261-38-5): Properties, Applications, and Research Insights
Ginkgolic Acid (C13:0), identified by its CAS number 20261-38-5, is a naturally occurring phenolic compound derived from the leaves and seeds of the Ginkgo biloba tree. This compound belongs to the alkylphenol family and is characterized by its 13-carbon side chain (C13:0), which contributes to its unique biological activities. In recent years, Ginkgolic Acid has garnered significant attention in the fields of natural product research, cosmetics, and pharmacology, particularly due to its potential anti-inflammatory, antimicrobial, and neuroprotective properties.
The growing interest in plant-derived bioactive compounds has positioned Ginkgolic Acid (C13:0) as a subject of extensive scientific inquiry. Researchers are increasingly exploring its mechanisms of action, particularly its ability to modulate cellular pathways linked to oxidative stress and inflammation. For instance, studies suggest that this compound may inhibit key enzymes like tyrosinase, making it a promising candidate for skin-lightening formulations and anti-aging skincare products. These applications align with current consumer trends favoring clean beauty and sustainable ingredients.
From a structural perspective, Ginkgolic Acid (C13:0) features a salicylic acid core with a long hydrophobic chain, which enhances its lipid solubility and membrane permeability. This property is critical for its bioavailability and interaction with cellular targets. Analytical techniques such as HPLC and mass spectrometry are commonly employed to quantify and characterize this compound in Ginkgo biloba extracts, ensuring purity and consistency for industrial applications.
In the realm of natural medicine, Ginkgolic Acid is often discussed alongside other Ginkgo biloba constituents like flavonoids and terpenoids. However, its distinct pharmacological profile sets it apart. Recent in vitro studies highlight its potential as an antibacterial agent against drug-resistant pathogens, a topic of high relevance given the global rise in antimicrobial resistance (AMR). This has spurred interest in developing Ginkgolic Acid-based therapeutics as complementary alternatives to conventional antibiotics.
Despite its benefits, the use of Ginkgolic Acid (C13:0) requires careful consideration due to reports of allergenic potential in sensitive individuals. Regulatory bodies emphasize the importance of quality control and standardization in commercial products containing this compound. Manufacturers are increasingly adopting green extraction methods, such as supercritical CO2 extraction, to minimize residual solvents and enhance sustainability—a practice highly valued in today’s eco-conscious market.
Looking ahead, the integration of Ginkgolic Acid into functional foods and nutraceuticals presents exciting opportunities. Its purported neuroprotective effects align with the booming market for cognitive health supplements, driven by an aging population and rising awareness of brain health. Furthermore, advancements in nanotechnology may enable targeted delivery systems to improve its efficacy and reduce side effects.
In summary, Ginkgolic Acid (C13:0) (CAS No. 20261-38-5) exemplifies the convergence of traditional knowledge and modern science. Its multifaceted applications—from cosmeceuticals to antimicrobial research—underscore its value as a bioactive natural compound. As research continues to unravel its full potential, this molecule is poised to play a pivotal role in addressing contemporary health and wellness challenges.